<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03260465</url>
  </required_header>
  <id_info>
    <org_study_id>2017-00832; mu21Stoffel</org_study_id>
    <nct_id>NCT03260465</nct_id>
  </id_info>
  <brief_title>Clinical Study With the seleXys PC and the RM Pressfit Vitamys Cup</brief_title>
  <official_title>A Randomized Controlled Trial With the seleXys PC Cup and RM Pressfit Vitamys Cup in Combination With the Optimys Short Stem</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized controlled trial with the seleXys PC cup and RM Pressfit vitamys cup in&#xD;
      combination with the optimys short stem. Wear rate and migration is assessed with roentgen&#xD;
      stereophotogrammetric analysis (RSA) measurements.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 30, 2017</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>prospective, randomised single-center study with 2 treatment arms.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Wear Rate</measure>
    <time_frame>3 years</time_frame>
    <description>The principal purpose of this study is to compare the modular seleXys PC Cup with a vitamys inlay to the monoblock RM Pressfit vitamys cup by means of wear rate. In addition, the migration of the two cups and the optimys stem, respectively, will be evaluated.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Hip Joint</condition>
  <condition>Arthritis, Degenerative</condition>
  <arm_group>
    <arm_group_label>seleXys PC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>seleXys PC cup combined with the optimys stem</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RM</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>RM Pressfit vitamys cup combined with the optimys stem</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>seleXys PC</intervention_name>
    <description>Total hip arthroplasty using the seleXys PC cup</description>
    <arm_group_label>seleXys PC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RM</intervention_name>
    <description>Total hip arthroplasty using the RM cup</description>
    <arm_group_label>RM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with symptomatic arthritis who are candidates for a primary total hip&#xD;
             arthroplasty with an uncemented femoral stem as determined jointly by the surgeon and&#xD;
             the patient.&#xD;
&#xD;
          -  Patients suitable for an uncemented acetabular component in combination with a 36mm&#xD;
             femoral head (seleXys PC cup: 52mm, 54mm or 56mm; RM Pressfit vitamys: 52mm, 54mm or&#xD;
             56mm)&#xD;
&#xD;
          -  Patients between the ages of 50 and 75 inclusive&#xD;
&#xD;
          -  Patients who understand the conditions of the study and are willing to participate for&#xD;
             the length of the prescribed follow-up&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients that require an acetabular cup size which cannot be used in combination with&#xD;
             a 36mm femoral head&#xD;
&#xD;
          -  Patients that offer no guarantee for regular follow-up controls&#xD;
&#xD;
          -  Patients that have a revision surgery&#xD;
&#xD;
          -  Patients that have a fracture of the femoral neck or a bone tumour in the area of the&#xD;
             femur or pelvis&#xD;
&#xD;
          -  Patients that had a previous osteotomy of the femur or pelvis&#xD;
&#xD;
          -  Pregnant women or those seeking to become pregnant&#xD;
&#xD;
          -  Patients with a history of active infection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karl Stoffel, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinik für Orthopädie und Traumatologie, Universitätsspital Basel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karl Stoffel, Prof. Dr. med.</last_name>
    <phone>+41 61 315 27 51</phone>
    <email>Karl.Stoffel@usb.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ilona Ahlborn</last_name>
    <phone>+41 61 328 71 97</phone>
    <email>ilona.ahlborn@usb.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Klinik für Orthopädie und Traumatologie, University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <state>BL</state>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karl Stoffel, Prof. Dr. med.</last_name>
      <phone>+41 (0) 61 9253841</phone>
      <email>Karl.Stoffel@usb.ch</email>
    </contact>
    <contact_backup>
      <last_name>Ilona Ahlborn</last_name>
      <phone>+41 61 328 71 97</phone>
      <email>ilona.ahlborn@usb.ch</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>August 22, 2017</study_first_submitted>
  <study_first_submitted_qc>August 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 24, 2017</study_first_posted>
  <last_update_submitted>February 1, 2021</last_update_submitted>
  <last_update_submitted_qc>February 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>total hip replacement</keyword>
  <keyword>roentgen stereophotogrammetric analysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

